Kamada Ltd., headquartered in Rehovot, Israel, is a leading biopharmaceutical firm focused on the development and commercialization of plasma-derived therapeutics for rare and complex diseases. Boasting a robust pipeline and proprietary technologies, Kamada is well-positioned to address significant unmet medical needs while improving patient outcomes through innovative therapies. The company’s dedication to advancing healthcare solutions and its agility in the rapidly changing biopharmaceutical landscape present a compelling investment opportunity for institutional investors looking to capitalize on high-growth prospects within the healthcare sector. Show more

Location: 2 HOLZMAN STREET, REHOVOT, ISRAEL, 7670402, Rehovot, 7670402, USA | Website: https://www.kamada.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE

Market Cap

462.6M

52 Wk Range

$5.54 - $8.90

Previous Close

$8.02

Open

$8.03

Volume

30,473

Day Range

$8.02 - $8.23

Enterprise Value

410M

Cash

72.0M

Avg Qtr Burn

N/A

Insider Ownership

7.20%

Institutional Own.

49.98%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Inhaled AAT Details Severe alpha-1 antitrypsin deficiency	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Anti-SARS-CoV-2 plasma-derived hyperimmune immunoglobulin (IgG) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.